Quantcast

Latest Inositol Stories

2010-07-14 09:33:00

We are advised by a representative for Upsher-Smith Laboratories, Inc. that journalists and other readers should disregard the news release, Shown to Support 'Good' Cholesterol (HDL), Slo-Niacin® Dietary Supplement Features a Unique, Patented Polygel® System to Deliver Controlled-Release Niacin, issued 14-Jul-2010 over PR Newswire. SOURCE Upsher-Smith Laboratories, Inc.

2010-04-07 13:55:54

Researchers from Boston University School of Medicine (BUSM) in collaboration with investigators at the University of Utah, have discovered a new approach for identifying smokers at the highest risk for developing lung cancer. The findings, which appear in the April 7th issue of Science Translational Medicine, will allow the researchers to use a genomic approach to prevent lung cancer in these individuals and to personalize cancer chemoprophylaxis and therapy. Cigarette smoke is the dominant...

cda1005f261f5ba111d7150b6fb23b49
2010-04-06 07:05:00

Highly dangerous Cryptococcus fungi love sugar and will consume it anywhere because it helps them reproduce. In particular, they thrive on a sugar called inositol which is abundant in the human brain and spinal cord. To borrow inositol from a person's brain, the fungi have an expanded set of genes that encode for sugar transporter molecules. While a typical fungus has just two such genes, Cryptococcus have almost a dozen, according to Joseph Heitman, M.D., Ph.D., chairman of the Duke...

2010-02-25 08:55:52

An early study suggests that vitamin B3 or niacin, a common water-soluble vitamin, may help improve neurological function after stroke, according to Henry Ford Hospital researchers. When rats with ischemic stroke were given niacin, their brains showed growth of new blood vessels, and sprouting of nerve cells which greatly improved neurological outcome. Now research is underway at Henry Ford to investigate the effects of an extended-release form of niacin on stroke patients. Henry Ford is the...

2009-04-21 11:43:08

Welsh researchers say they've discovered a possible mechanism that Lithium uses to combat bipolar disorders, suggesting more effective treatments. Lithium has been one of the most effective treatments for biopolar disorders for more than 50 years, yet scientists have never been entirely sure how it operates in the human brain. But now Cardiff University scientists say laboratory tests on cells have shown Lithium affects a molecule called PIP3 that is important in controlling brain-cell...

2009-04-21 11:11:54

Potential mechanism identified for Lithium operation in the brain Lithium has been established for more than 50 years as one of the most effective treatments for bipolar mood disorder. However, scientists have never been entirely sure exactly how it operates in the human brain. Now, new research from Cardiff University scientists suggests a mechanism for how Lithium works, opening the door for potentially more effective treatments. Laboratory tests on cells have shown that Lithium affects a...

2008-10-28 09:00:39

Cortria Corporation, a clinical-stage pharmaceutical company focused on developing safe and well-tolerated medicines to fight cardiovascular disease, today announced that TRIA-662 has been selected as one of the Top 10 most promising cardiovascular projects in development. TRIA-662 is currently in Phase 2 clinical development for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. "We are excited that Windhover has selected...

2008-09-18 09:00:49

Cortria Corporation today announced the formation of a Scientific Advisory Board (SAB) comprised of distinguished cardiologists, clinical researchers and globally-recognized experts in the field of dyslipidemia. Members of the Cortria Scientific Advisory Board include: -Jean-Claude Tardif, M.D., Professor of Medicine and Director of the Research Center, Montreal Heart Institute (Chairman of Cortria Scientific Advisory Board) -H. Bryan Brewer, M.D., Director of Lipoprotein and...

2008-08-11 09:01:40

Cortria Corporation today announced the appointment of Gene Cefali, Pharm.D, Ph.D., as Senior Vice President of Clinical Pharmacology and Formulation Development. Dr. Cefali was previously Vice President of Lead Optimization at Kos Pharmaceuticals (acquired by Abbott Laboratories), where he played a major role in the development of Niaspan(R), a novel formulation of niacin and widely prescribed anti-dyslipidemic medicine, as well as three Niaspan(R) line-extension products. Dr. Cefali is a...

2008-01-14 15:00:40

DEAR DR. GOTT: My husband and I both are taking niacin for our cholesterol. When we first started taking it, we bought regular niacin. The side effect of extreme flushing was very uncomfortable. We then switched to flush-free niacin. When we switched, we both saw our physicians. One said the properties that caused the flushing were necessary to control the cholesterol. The other doctor said he was unaware of that problem. Would you give us your opinion as to whether flush-free is or is not...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.